This is a demo store. No orders will be fulfilled.

Methazolamide - 98%, high purity , CAS No.554-57-4, Inhibitor of carbonic anhydrase 1;Inhibitor of carbonic anhydrase 12;Inhibitor of carbonic anhydrase 14;Inhibitor of carbonic anhydrase 4;Inhibitor of carbonic anhydrase 7

In stock
Item Number
M303972
Grouped product items
SKU Size
Availability
Price Qty
M303972-250mg
250mg
2
$35.90
M303972-1g
1g
2
$116.90
M303972-5g
5g
2
$351.90

Potent, cell-permeable carbonic anhydrase inhibitor

Basic Description

Synonyms HMS2093A05 | KBio2_002095 | Oprea1_161738 | Acetamide, N-(4-methyl-2-sulfamoyl-.delta.2-1,3,4-thiadiazolin-5-ylidene)- | SPECTRUM1503252 | BRN 0232387 | FLOSMHQXBMRNHR-QPJJXVBHSA-N | Prestwick1_000802 | 4-27-00-08221 (Beilstein Handbook Reference) | Methe
Specifications & Purity Moligand™, ≥98%
Biochemical and Physiological Mechanisms Methazolamide has a plasma half-life of 14 hours in humans. Methazolamide has relatively good lipid solubility and low plasma protein binding ability. Thus, it diffuses into tissues and fluids much more readily than acetazolamide, another carbonic anhydra
Storage Temp Store at -20°C
Shipped In
Ice chest + Ice pads
This product requires cold chain shipping. Ground and other economy services are not available.
Grade Moligand™
Action Type INHIBITOR
Mechanism of action Inhibitor of carbonic anhydrase 1;Inhibitor of carbonic anhydrase 12;Inhibitor of carbonic anhydrase 14;Inhibitor of carbonic anhydrase 4;Inhibitor of carbonic anhydrase 7
Note Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.
Product Description

Methazolamide (L584601) is a sulfonamide derivative used as a carbonic anhydrase inhibitor with a Ki of 14 nM for human carbonic anhydrase II. Methazolamide, an intraocular pressure-lowering agent, reduces intraocular pressure elevations associated with glaucoma and other ocular disorders

Taxonomic Classification

Taxonomy Tree

Kingdom Organic compounds
Superclass Organoheterocyclic compounds
Class Azoles
Subclass Thiadiazoles
Intermediate Tree Nodes Not available
Direct Parent Thiadiazole sulfonamides
Alternative Parents Organosulfonamides  Heteroaromatic compounds  Aminosulfonyl compounds  N-acylimines  Carboxylic acids and derivatives  Azacyclic compounds  Organopnictogen compounds  Organic oxides  Hydrocarbon derivatives  Carbonyl compounds  
Molecular Framework Aromatic heteromonocyclic compounds
Substituents 1,3,4-thiadiazole-2-sulfonamide - Organosulfonic acid amide - Organic sulfonic acid or derivatives - Organosulfonic acid or derivatives - Sulfonyl - Heteroaromatic compound - Aminosulfonyl compound - N-acylimine - Carboxylic acid derivative - Azacycle - Carbonyl group - Hydrocarbon derivative - Organic oxide - Organopnictogen compound - Organic oxygen compound - Organosulfur compound - Organooxygen compound - Organonitrogen compound - Organic nitrogen compound - Aromatic heteromonocyclic compound
Description This compound belongs to the class of organic compounds known as thiadiazole sulfonamides. These are heterocyclic compounds containing a thiazole ring substituted by at least one sulfonamide group.
External Descriptors Not available

Associated Targets(Human)

CA1 Tclin Carbonic anhydrase 1 (0 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)
CA4 Tclin Carbonic anhydrase 4 (1 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)
CA12 Tclin Carbonic anhydrase 12 (1 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)
CA14 Tclin Carbonic anhydrase 14 (1 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)
CA7 Tclin Carbonic anhydrase 7 (1 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)

Names and Identifiers

Pubchem Sid 504750745
Pubchem Sid Url https://pubchem.ncbi.nlm.nih.gov/substance/504750745
IUPAC Name N-(3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2-ylidene)acetamide
INCHI InChI=1S/C5H8N4O3S2/c1-3(10)7-4-9(2)8-5(13-4)14(6,11)12/h1-2H3,(H2,6,11,12)
InChIKey FLOSMHQXBMRNHR-UHFFFAOYSA-N
Smiles CC(=O)N=C1N(N=C(S1)S(=O)(=O)N)C
Isomeric SMILES CC(=O)N=C1N(N=C(S1)S(=O)(=O)N)C
Molecular Weight 236.3
Reaxy-Rn 232387
Reaxys-RN_link_address https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=232387&ln=

Certificates(CoA,COO,BSE/TSE and Analysis Chart)

C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

5 results found

Lot Number Certificate Type Date Item
J2112249 Certificate of Analysis Aug 08, 2024 M303972
J2112612 Certificate of Analysis Aug 08, 2024 M303972
C2313675 Certificate of Analysis Dec 07, 2022 M303972
C2313584 Certificate of Analysis Dec 07, 2022 M303972
C2313678 Certificate of Analysis Dec 07, 2022 M303972

Chemical and Physical Properties

Solubility DMSO: 20 mg/mL, clear
Sensitivity light sensitive
Melt Point(°C) 208°C
Molecular Weight 236.300 g/mol
XLogP3 0.100
Hydrogen Bond Donor Count 1
Hydrogen Bond Acceptor Count 6
Rotatable Bond Count 1
Exact Mass 236.004 Da
Monoisotopic Mass 236.004 Da
Topological Polar Surface Area 139.000 Ų
Heavy Atom Count 14
Formal Charge 0
Complexity 419.000
Isotope Atom Count 0
Defined Atom Stereocenter Count 0
Undefined Atom Stereocenter Count 0
Defined Bond Stereocenter Count 0
Undefined Bond Stereocenter Count 0
The total count of all stereochemical bonds 0
Covalently-Bonded Unit Count 1

Citations of This Product

1. Junrong Li, Yingjun Wang, Ziqi Fan, Panyang Tang, Mengting Wu, Hong Xiao, Zhenxing Zeng.  (2023)  Toxicity of Tetracycline and Metronidazole in Chlorella pyrenoidosa.  International Journal of Environmental Research and Public Health,  20  (4): (3623). 
2. Da Wang, Zhe Yang, Yinning He, Shiwen Dong, Feilong Dong, Zhiqiao He, Xiaohui Lu, Lizhang Wang, Shuang Song, Jun Ma.  (2023)  Metribuzin and metamitron degradation using catalytic ozonation over tourmaline: Kinetics, degradation pathway, and toxicity.  SEPARATION AND PURIFICATION TECHNOLOGY,  309  (123028). 
3. Haojiang Wang, Wenli Hu, Qiong Zheng, Wei Bian, Zian Lin.  (2017)  One-pot preparation of mercaptotetrazole-silica hybrid monoliths by the thiol-ene click reaction for mixed-mode capillary liquid chromatography.  JOURNAL OF SEPARATION SCIENCE,  40  (11): (2344-2354). 

Solution Calculators

Reviews

Customer Reviews

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.